INFORMED.
LIVE

Marksans Pharma Ltd.

BSE: MARKSANS524404ISIN INE750C01026
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹319.80+0.65 (+0.20%)
as of 18 Sep 2026
Marksans Pharma Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹178.35 to ₹319.80 (+79.3%). Low ₹162.55, high ₹335.15. Volume shown below the price.
52W high
₹349.70
52W low
₹156.00
Off 52W high
-8.55%
1M return
-2.34%
3M return
+22.91%
6M return
+88.39%
1Y return
+79.31%
20D avg volume
1,56,215
50 DMA
₹297.05
200 DMA
₹221.45

Key ratios Consolidated

Market cap
₹14,492 Cr
Current price
₹319.80
52W high / low
₹349.70 / ₹156.00
Face value
₹1.00
P/E
27.80
P/B
EPS (TTM)
₹11.50
Book value / share
ROE
ROCE
17.50%
Operating margin
Net margin
Debt / equity
0.01
Net debt
₹-604.55 Cr
Interest cover
24.24
Dividend yield
0.28%
Dividend / share (TTM)
₹0.90
Payout
7.83%
Cash conversion cycle
158.3 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
840.80856.11754.43720.41619.9970.85
25.4035.1720.1421.575.641.65
659.63691.29623.95608.65549.0360.89
220.67264.97273.82227.72192.6918.81
138.45149.8126.99106.14171.5516.10
114.29106.76111.99103.8098.399.72
7.006.315.935.826.070.34
24.8624.2924.3326.9223.102.27
170.00163.28165.47163.52159.6716.03
206.57200.00150.62133.3376.6011.61
0.000.000.000.000.000.00
206.57200.00150.62133.3376.6011.61
47.1650.9736.9334.2018.402.54
159.41149.03113.6999.1458.209.07
3.473.272.502.171.292.00
Key metrics
238.43230.60180.88166.07105.7714.22
28.40%26.90%24.00%23.10%17.10%20.10%
19.00%17.40%15.10%13.80%9.40%12.80%
6.20%4.70%4.30%
35.60%1,108.30%
173.90%1,543.10%
MetricTTMFY26FY25FY24
Income statement
3,1722,951262.28
102.2882.537.04
2,5842,473218.93
987.18959.2175.30
421.39454.4957.45
436.84420.9335.03
25.0624.121.17
100.4098.638.34
662.27651.9560.02
690.52560.5550.40
0.000.000.00
690.52560.5550.40
169.26140.4912.13
521.27420.0638.26
11.419.228.40
Key metrics
815.98683.3059.91
25.73%23.20%22.80%
16.43%14.20%14.60%
17.50%18.70%
1,025.10%
997.90%
327.593.38
1.090.54
0.010.01
-604.55-47.27
158.3150.3
Balance sheet
3,861323.96
2,723220.41
634.1449.58
644.5754.00
972.2884.55
9.78
625.0157.95
336.9130.57
527.0947.73
29.592.31
29.592.31
0.000.00
3,053248.94
Cash flow
458.1220.67
-248.27-4.90
-70.93-6.51
130.5317.29
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
321.19361.57339.73320.44319.73299.36
17.4727.4815.8658.192.017.82
248.20264.69273.47257.14258.17257.27
141.64159.48151.00146.66145.28145.06
18.0313.2616.0220.9922.8016.77
31.7732.9132.7028.4627.9028.82
0.340.350.360.320.300.31
8.788.768.838.468.198.18
49.4647.3458.3854.4356.9955.84
90.46124.3682.12121.4963.5749.90
0.000.000.000.000.000.00
90.46124.3682.12121.4963.5749.90
21.4232.4421.2021.6915.5212.31
69.0491.9260.9199.8148.0637.59
1.522.031.342.201.060.83
Key metrics
99.58133.4791.31130.2772.0658.39
31.00%36.90%26.90%40.70%22.50%19.50%
21.50%25.40%17.90%31.10%15.00%12.60%
7.40%8.00%3.60%
0.50%20.80%
43.70%144.50%
MetricTTMFY26FY25FY24
Income statement
1,3431,3411,174
119.00103.5369.83
1,0441,0531,001
598.78602.43537.18
68.3073.06102.06
125.84121.98101.68
1.371.331.17
34.8334.2329.45
209.61217.15228.71
418.43391.54243.26
0.000.000.00
418.43391.54243.26
96.7590.8454.99
321.68300.70188.27
7.096.644.15
Key metrics
454.63427.10273.88
33.85%31.80%23.30%
23.95%22.40%16.00%
23.30%17.30%
14.20%
59.70%
162.31-88.89
0.700.16
0.000.00
-91.25-60.27
171.9171.3
Balance sheet
1,9941,755
1,3091,082
91.2560.27
623.46549.58
189.13205.21
55.71
368.68353.59
180.81203.53
310.25345.63
0.000.00
0.000.00
0.000.00
1,6521,383
Cash flow
211.0931.02
-140.2917.24
-39.23-29.92
48.78119.91

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
43.87%
HolderTypeHoldingPreviousChange
MARK SALDANHAPromoter43.80%
ORBIMED ASIA IV MAURITIUS FVCI LIMITEDPublic8.62%
UTI-HEALTHCARE FUNDPublic2.11%
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK SPECIAL OPPORTUNITIES FUNDPublic1.14%
SANDRA SALDANHAPromoter0.07%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 0.900020 Aug 202620 Aug 2026
Final Dividend - Rs. - 0.80001 Aug 20251 Aug 2025
Final Dividend - Rs. - 0.600017 Sep 202417 Sep 2024

Board meetings

  • Board Meeting - Financial Results